Clinical Trial Update: A Pharmacokinetic Study of AA4500 (XIAFLEX™, Proposed Name) in Subjects With Dupuytren's Contracture [Phase 1]

View source ↗

Summary

Phase 1 PK study of AA4500 (XIAFLEX, proposed name) in subjects with Dupuytren's Contracture has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dupuytren Contracture

Drugs mentioned

• XIAFLEX (Collagenase Clostridium histolyticum)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Dupuytren's Contracture | Phase 1 | Status: COMPLETED | Results posted: 2012-08-20